CTXR
NASDAQ · Pharmaceuticals
Citius Pharmaceuticals Inc
$0.54
-0.01 (-2.63%)
Open$0.57
Previous Close$0.55
Day High$0.65
Day Low$0.52
52W High$1.67
52W Low$0.37
Volume—
Avg Volume343.6K
Market Cap14.56M
P/E Ratio—
EPS$-2.13
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+617.6% upside
Current
$0.54
$0.54
Target
$3.85
$3.85
$3.27
$3.85 avg
$6.37
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.36M | 3.56M | 3.14M |
| Net Income | 635.6K | 690.8K | 743.5K |
| Profit Margin | 18.9% | 19.4% | 23.7% |
| EBITDA | 1.24M | 1.20M | 1.26M |
| Free Cash Flow | 627.5K | 529.6K | 500.9K |
| Rev Growth | -2.5% | +1.7% | -0.7% |
| Debt/Equity | 1.45 | 1.39 | 1.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,368.84 | +0.30% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $274.87 | +0.94% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $147.01 | +0.05% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.30 | -1.94% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $62.89 | -0.38% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $79.81 | -2.80% | 12.3 | 32.24B |